Q4 2024 |
80 |
$1.32B |
+$555M |
-$359M |
+$196M |
NVCR, TGTX, BMRN, KRYS, GRFS
|
13F-HR |
2/14/2025, 02:14 PM |
Q3 2024 |
86 |
$1.2B |
+$312M |
-$372M |
-$60.2M |
IOVA, TGTX, TERN, AXGN, GRFS
|
13F-HR |
11/14/2024, 12:51 PM |
Q2 2024 |
92 |
$1.13B |
+$389M |
-$302M |
+$86.9M |
TGTX, IOVA, UTHR, NRIX, EDAP
|
13F-HR |
8/14/2024, 01:40 PM |
Q1 2024 |
89 |
$1.14B |
+$454M |
-$350M |
+$104M |
UTHR, EDAP, IOVA, TEVA, TGTX
|
13F-HR |
5/15/2024, 01:15 PM |
Q4 2023 |
73 |
$901M |
+$193M |
-$441M |
-$248M |
TEVA, UTHR, GSK, RYZB, EDAP
|
13F-HR |
2/14/2024, 02:51 PM |
Q3 2023 |
126 |
$1.08B |
+$431M |
-$203M |
+$228M |
XBI, UTHR, TEVA, EDAP, SRDX
|
13F-HR |
11/14/2023, 01:51 PM |
Q2 2023 |
116 |
$900M |
+$280M |
-$416M |
-$136M |
UTHR, EDAP, CRL, SRDX, ORGO
|
13F-HR |
8/14/2023, 03:02 PM |
Q1 2023 |
77 |
$966M |
+$481M |
-$60.1M |
+$421M |
XBI, EDAP, ISEE, ACLX, CRL
|
13F-HR |
5/15/2023, 01:57 PM |
Q4 2022 |
72 |
$697M |
+$169M |
-$198M |
-$29M |
EDAP, ISEE, UTHR, BCAB, ACLX
|
13F-HR |
2/14/2023, 02:18 PM |
Q3 2022 |
76 |
$736M |
+$286M |
-$116M |
+$170M |
UTHR, ISEE, EDAP, SKIN, ILMN
|
13F-HR |
11/14/2022, 01:15 PM |
Q2 2022 |
72 |
$641M |
+$238M |
-$57.4M |
+$181M |
UTHR, SKIN, ORGO, SRDX, EDAP
|
13F-HR |
8/15/2022, 02:43 PM |
Q1 2022 |
65 |
$775M |
+$344M |
-$174M |
+$170M |
XBI, UTHR, EPIX, SRDX, EDAP
|
13F-HR |
5/16/2022, 03:13 PM |
Q4 2021 |
68 |
$999M |
+$543M |
-$31.3M |
+$511M |
XBI, IWM, LNTH, EPIX, BCAB
|
13F-HR |
2/14/2022, 10:17 AM |
Q3 2021 |
72 |
$642M |
+$219M |
-$145M |
+$73.5M |
BCAB, CCCC, LNTH, DICE, THTXXXXX
|
13F-HR |
11/15/2021, 11:16 AM |
Q2 2021 |
65 |
$650M |
+$243M |
-$134M |
+$109M |
BCAB, EPIX, CCCC, NPCE, THTXXXXX
|
13F-HR |
8/16/2021, 02:02 PM |
Q1 2021 |
72 |
$555M |
+$178M |
-$74.7M |
+$103M |
BCAB, EPIX, THTXXXXX, ISEE, LNTH
|
13F-HR |
5/17/2021, 12:48 PM |
Q4 2020 |
65 |
$758M |
+$621M |
-$59.4M |
+$562M |
XBI, BCAB, EPIX, GLTO, ISEE
|
Restatement |
4/28/2021, 05:34 PM |
Q3 2020 |
63 |
$189M |
+$81.7M |
-$38.6M |
+$43M |
EPIX, ISEE, OSUR, MRSN, INBX
|
13F-HR |
11/13/2020, 12:17 PM |
Q2 2020 |
61 |
$175M |
+$99M |
-$22.2M |
+$76.8M |
ZYME, EPIX, ZYME, ISEE, AZN
|
13F-HR |
8/14/2020, 12:50 PM |
Q1 2020 |
48 |
$85.9M |
+$36.6M |
-$12.8M |
+$23.7M |
EPIX, GRFS, ISEE, HARPXXXX, IRMD
|
13F-HR |
5/15/2020, 12:15 PM |
Q4 2019 |
49 |
$104M |
|
|
|
GRFS, EPIX, WMGI, ISEE, AGN
|
13F-HR |
2/14/2020, 09:43 AM |